CIK: 0001615982 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 14, 2022
Total Value ($000): $731,539 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Instil Bio Inc | 6,865,076 | $117,461 | 16.1% | $25.08 | — | COM | 45783C101 |
| ACRS | Aclaris Therapeutics Inc | 4,563,962 | $66,360 | 9.1% | $13.57 | +11.6% | COM | 00461U105 |
| TVTX | Travere Therapeutics Inc | 1,994,997 | $61,925 | 8.5% | $19.66 | +43.2% | COM | 89422G107 |
| RLMD | Relmada Therapeutics Inc | 2,270,072 | $51,145 | 7.0% | $31.54 | -29.5% | COM | 75955J402 |
| GHRS | GH Research PLC | 2,021,985 | $47,173 | 6.4% | $20.70 | +6.1% | ORD SH | G3855L106 |
| WHWK | Aadi Bioscience Inc | 1,529,402 | $36,935 | 5.0% | $30.48 | -17.6% | COM | 00032Q104 |
| VRDN | Viridian Therapeutics Inc | 1,852,919 | $36,632 | 5.0% | $18.59 | +0.2% | COM | 92790C104 |
| — | Marinus Pharmaceuticals Inc | 2,880,096 | $34,216 | 4.7% | $12.23 | — | COM | 56854Q200 |
| CLDX | Celldex Therapeutics Inc | 865,116 | $33,428 | 4.6% | $15.71 | +177.4% | COM | 15117B202 |
| — | Tricida Inc | 3,494,851 | $33,411 | 4.6% | $9.01 | — | COM | 89610F101 |
| LIANY | LianBio | 5,378,341 | $33,131 | 4.5% | $6.16 | — | SPONS ADR | 53000N108 |
| — | VistaGen Therapeutics Inc | 16,047,286 | $31,292 | 4.3% | $2.02 | — | COM | 92840H202 |
| — | Chinook Therapeutics Inc | 1,283,821 | $20,939 | 2.9% | $16.31 | — | COM | 16961L106 |
| — | Graphite Bio Inc | 1,612,617 | $20,045 | 2.7% | $30.73 | — | COM | 38870X104 |
| NUVL | Nuvalent Inc | 803,951 | $15,307 | 2.1% | $29.01 | -23.2% | COM | 670703107 |
| — | Kinnate Biopharma Inc | 773,014 | $13,698 | 1.9% | $39.78 | — | COM | 49705R105 |
| — | Athira Pharma Inc | 1,000,000 | $13,030 | 1.8% | $20.05 | — | COM | 04746L104 |
| CNTA | Centessa Pharmaceuticals PLC | 1,127,272 | $12,693 | 1.7% | $22.21 | — | SPONS ADR | 152309100 |
| ATYR | aTyr Pharma Inc | 1,565,000 | $11,691 | 1.6% | $5.98 | +39.5% | COM | 002120202 |
| COGT | Cogent Biosciences Inc | 1,088,817 | $9,342 | 1.3% | $10.99 | -20.9% | COM | 19240Q201 |
| — | Affimed NV | 1,428,571 | $7,886 | 1.1% | $5.52 | — | COM | N01045108 |
| OLMA | Olema Pharmaceuticals Inc | 816,651 | $7,644 | 1.0% | $46.89 | -55.8% | COM | 68062P106 |
| CVRX | CVRx Inc | 533,370 | $6,523 | 0.9% | $28.00 | -48.2% | COM | 126638105 |
| — | Akoya Biosciences Inc | 400,000 | $6,124 | 0.8% | $19.34 | — | COM | 00974H104 |
| — | Astria Therapeutics Inc | 538,999 | $2,905 | 0.4% | $8.84 | — | COM | 04635X102 |
| CRVS | Corvus Pharmaceuticals Inc | 250,000 | $603 | 0.1% | $2.96 | +31.0% | COM | 221015100 |